Posaconazole intemediate / main ring CAS NO.149809-43-8

Min.Order: 10 Gram
Payment Terms: L/C,T/T

Product Details

Keywords

(5R-cis)-Toluene-4-sulfonic acid 5-(2,4-difluorophenyl)-5-(1H-1,2,4-triazol-1-yl)methyltetrahydrofuran-3-ylmethyl ester
Chiral Reactive Intermediate
commercial production from grams to tons, with technical documents support and audit/inspection support

Quick Details

ProName: Posaconazole intemediate / main ring
CasNo: 149809-43-8
Molecular Formula: C21H21F2N3O4S
Appearance: white powder
Application: Posaconazole intemediate
DeliveryTime: within 4 weeks
PackAge: standard package
Port: TBC
ProductionCapacity: commercial production Metric Ton/Day
Purity: 99%
Storage: room temperature
Transportation: Non-Hazardous
LimitNum: 10 Gram
Moisture Content: ≤0.5%
Impurity: ≤1.0%
any individual impurity: ≤ 0.15%

Superiority

Multi-target purpose intermediate with wide usage

Commercial production from grams to tons, with technical documents package support, and audit and inspection support.

With high purity and optimized and stable process.

Self Innovation

Details

SENOVA PHARMA is committed to the development and production of API’s, advanced intermediates and biochemical products.

We insist on product development and production technology platform combining chemical synthesis (drug synthesis) technology, enzyme synthesis (biocatalytic and biotransformation) technology and microbial fermentation (biosynthesis) technology.

Our own production base and our cooperative plants in China produce products according to cGMP application, providing customers with stable and reliable whole-chain solutions， esp in anti-tumor and anti-cancer fields.